Gemcitabine monotherapy

DRUG2 trials

Sponsors

Chinese PLA General Hospital, AstraZeneca

Conditions

Biliary Tract CancerCancer of Pancreas

Phase 2

Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients

Chinese PLA General HospitalCancer of Pancreas

Start: 2017-10-01End: 2018-09-30Target: 90Updated: 2017-09-11

Phase 3

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Active, not recruitingNCT05771480

AstraZenecaBiliary Tract Cancer

Start: 2023-08-16End: 2026-09-17Updated: 2026-03-25

Related Papers

TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer.

Journal of Clinical Oncology2024-06-011 citations